Closed System Transfer Devices Market Analysis and Forecast to 2031: By Closing Mechanism (Push-to-Lock System, Click-to-Lock System, Luer Lock System, Color-to-Color Alignment System), Type (Membrane to Membrane Systems, Needleless Systems), Component (V

Closed System Transfer Devices Market Analysis and Forecast to 2031: By Closing Mechanism (Push-to-Lock System, Click-to-Lock System, Luer Lock System, Color-to-Color Alignment System), Type (Membrane to Membrane Systems, Needleless Systems), Component (Vial Access Devices, Syringe Safety Devices, Bag/Line Access Devices, Accessories), End User (Hospitals & Clinics, Oncology Centers, Others), and Region

The global closed system transfer devices market was valued at USD 914.0 Million in 2021 and it is anticipated to grow at 18.1% CAGR during the forecast period to reach up to USD 4834.1 Million by 2031.

A closed system transfer device or "CSTD" is a drug transfer device, which mechanically restricts the transfer of environmental contamination in the medical system and the escape of hazardous drug or vapor concentrations outside the system. Open versus closed systems are commonly applied in medical devices to maintain the sterility of a fluid pathway. CSTDs work by preventing- uncontrolled inflow and outflow of contaminants and drugs, preserving the quality of the solution to be infused into a patient. These devices ensure the safety of healthcare workers during the usage of hazardous drugs or chemicals. Closed system transfer device designs and models have changed at a rapid rate in recent years, resulting in the development of a number of independent testing methodologies to assess closed system transfer device performance. Currently, manufacturers in the closed system transfer devices market are focusing more on adhering to performance requirements, which largely focus on patient safety and sterile practices.

Global Closed System Transfer Devices Market Scope and Report Structure

Market Trends and Drivers

The key factors such as rising use of CSTDs to combat the harmful effect of cytotoxic and antineoplastic drugs. Antineoplastic drugs are widely used in the treatment of cancer and are considered hazardous drugs. Healthcare workers involved in the preparation, transport, distribution, administration (pre and post-administration), and disposal of these drugs are at extremely high risk. The National Institute for Occupational Safety and Health (NIOSH) recommends the use of CSTDs to eliminate the harmful effects caused by exposure to hazardous substances that escape out of the system during drug preparation and administration. CSTDs act as a barrier and prevents the entry of contaminants prevent the transfer of contaminants from the atmosphere to a sterile environment. Due to these advantages, CSTDs are increasingly being used in healthcare facilities to combat the harmful effects of hazardous drugs.

Chemotherapy, a widely adopted cancer treatment, uses one or more antineoplastic drugs, which destroy abnormal cells in patients. The use of closed system transfer devices (CSTDs) in conjunction with other safety precautions such as gloves, gowns, masks, and vented preparation hoods is an effective way to increase safety when preparing, transporting, administering, and disposing of hazardous drugs. With the increasing incidence of cancer and increasing adoption of chemotherapy treatments, the demand for CSTDs is expected to increase in the upcoming years.

Market Restraints and Challenges

The major factor hindering the market growth is the high cost of implementation of CSTDs and lack of reimbursement. The cost of a closed system transfer device is one of the major constraints limiting its adoption in healthcare facilities. The cost of a typical CSTD primarily depends upon factors like manufacturer, components used, and drug that is to be administered. Moreover, since CSTDs are meant for single-use, the cost per unit is higher than regular syringes. The median price of CSTD ranges between USD8-12 per dose. According to the regulatory guidelines, CSTDs are categorized as IV consumables. Its usage is not mandatory in European and other developing nations. Since the use of these devices is absolutely voluntary in these countries, its reimbursement is unlikely. Hence, the lack of standard guidelines further acts as a hindrance to the adoption of these devices.

Global Closed System Transfer Devices Market Segmentation

The report analyses the global closed system transfer devices market based on closing mechanism, type, component, end user, and region.

Global Closed System Transfer Devices Market by Closing Mechanism

Based on the closing mechanism, it is segmented into the push to lock system, click to lock system, Luer lock system, and color to color alignment system. Color to color alignment system is likely to dominate the market during the forecast period. Owing to its unique structure that prevents leaks, spills, or the escape of vapors and aerosols. These devices equalize the pressure within the system when fluids are withdrawn or injected into vials. Additionally, the low cost of this system, along with its advantages, increased its adoption among pharmacists, oncologists, and nurses.

Global Closed System Transfer Devices Market by Type

Based on type, it is segmented into the membrane to membrane systems, and needleless systems. The membrane to membrane system is anticipated to dominate the market during the forecast period. The key factors such as ease of operation and lower risk of contamination associated with double membrane containment systems are boosting the market growth.

Global Closed System Transfer Devices Market by Component

Based on component, it is segmented into vial access devices, syringe safety devices, bag/line access devices, and accessories. The vial access devices segment is estimated to dominate the market during the forecast period. The key factors such as rising adoption of CSTDs products and vial access device by oncology nurses to transfer hazardous drugs from packaged vials to the infusion bag or the patient.

Global Closed System Transfer Devices Market by End User

Based on end user, it is segmented into hospitals & clinics, oncology centers, and other end users. The hospitals & clinics segment is likely to dominate the market during the forecast period. The large share and high growth of this segment are primarily owing to the strong financial capabilities of hospitals for purchasing high-priced CSTDs, the large cancer patient pool, and the need to comply with regulatory guidelines.

Geographical Analysis of Closed System Transfer Devices Market

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America is likely to dominate the market during the forecast period. The key factors such as easy accessibility to advanced technologies, high awareness about CSTD among oncologists, nurses, and pharmacists, and the presence of many CSTD manufacturing players in the region coupled with high incidences of cancer.

Major Players in Closed System Transfer Devices Market

COVID-19 Impact

The outbreak of COVID-19 led to a decrease in the demand for CSTDs during the first two quarters of 2020. Due to the virus containment norms and nationwide lockdowns, there were limited patient footfalls in hospitals, mostly related to COVID-19 and emergency cases. The elective medical procedures are on hold thereby causing a negative shift in the demand for CSTDs. Still, with the decline in the number of active COVID-19 cases coupled with the economic recovery in developed nations, further utilization of these devices may be expected in the near future.

Recent Developments

• January 2021, Simplivia Healthcare acquired 70% of Novame d, a diagnostic company that develops and manufactures a range of diagnostic kits to meet evolving trends of home care.
• May 2021, BD expanded its drug delivery devices segment by establishing a high-tech manufacturing facility in Zaragoza, Spain.
• May 2021, Yukon Medical received US FDA clearance for Arisure closed system transfer device under the ONB product classification.
• November 2020, Equashield LLC partnered with Syntronic Hospitalar to introduce Equashield’s products in Brazil.

Frequently Asked QuestionsQ. How big is the closed system transfer devices market?Ans. The global closed system transfer devices market size was USD 914.0 Billion in 2021 and is anticipated to reach USD 4834.1 Billion in 2031, growing at a rate of 18.1% from 2022 to 2031.Q. What is the closed system transfer devices market growth rate?Ans. The growth rate of the closed system transfer devices market is 18.1% from 2022 to 2031.Q. Which region holds a major market share for the closed system transfer devices market?Ans. North America holds a major market share of the closed system transfer devices market in 2021.Q. Which segment accounted for the largest closed system transfer devices market share?Ans. By closing mechanism, the color to color alignment system segment accounted for the largest closed system transfer devices market share.Q. Who are the key players in the closed system transfer devices market?Ans. The global closed system transfer devices market report includes players such as B. Braun Holding GmbH & Co. KG, Baxter International, Becton, Dickinson and Company, Caragen Ltd, Corvida Medical, Equashield, FIMI Opportunity Funds (Simplivia Healthcare), ICU Medical, JCB Co Ltd. (JMS Co Ltd.), Yukon Medical.Q. What are the factors driving the closed system transfer devices market growth?Ans. The major factors driving the growth of the market are the increasing R&D.Q. What are the key growth strategies of closed system transfer devices market players?Ans. The key growth strategies of closed system transfer devices market players are product launch and product approval.Q. Which region will provide more business opportunities for the closed system transfer devices market during the forecast period?Ans. The Asia-Pacific region will provide more business opportunities for the closed system transfer devices market during the forecast period.

Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.